Global Hydroxychloroquine Sulphate Market Growth 2025-2031

The global Hydroxychloroquine Sulphate market size is predicted to grow from US$ 893 million in 2025 to US$ 1004 million in 2031; it is expected to grow at a CAGR of 2.0% from 2025 to 2031.

Hydroxychloroquine sulfate was listed in the United States in 1955 and used in malaria, rheumatoid arthritis and lupus erythematosus. The variety has been approved in more than 70 countries such as Canada, France, Germany, Australia, China, Japan, etc.

Hydroxychloroquine sulfate, initially an anti malarial drug, was found to have mild immunosuppressive and immunomodulatory effects in clinical practice.

The major producers in the industry are Sanofi, Novartis and Shanghai Zhongxisanwei, with their revenue ratios of 36.07%, 14.20% and 15.08% respectively in 2019.

LP Information, Inc. (LPI) ' newest research report, the “Hydroxychloroquine Sulphate Industry Forecast” looks at past sales and reviews total world Hydroxychloroquine Sulphate sales in 2024, providing a comprehensive analysis by region and market sector of projected Hydroxychloroquine Sulphate sales for 2025 through 2031. With Hydroxychloroquine Sulphate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxychloroquine Sulphate industry.

This Insight Report provides a comprehensive analysis of the global Hydroxychloroquine Sulphate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxychloroquine Sulphate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hydroxychloroquine Sulphate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxychloroquine Sulphate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxychloroquine Sulphate.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxychloroquine Sulphate market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
100mg
200mg
Others

Segmentation by Application:
Lupus Erythematosus
Rheumatoid Arthritis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hydroxychloroquine Sulphate market?

What factors are driving Hydroxychloroquine Sulphate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hydroxychloroquine Sulphate market opportunities vary by end market size?

How does Hydroxychloroquine Sulphate break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.